HomeInsightsStock Comparison

Albert David Ltd vs Laurus Labs Ltd Stock Comparison

Albert David Ltd vs Laurus Labs Ltd Stock Comparison

Last Updated on: Aug 02, 2025

Key Highlights

  • The Latest Trading Price of Albert David Ltd is ₹ 873.3 as of 01 Aug 15:30.
  • The P/E Ratio of Albert David Ltd changed from 0 on March 2020 to 0 on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Laurus Labs Ltd changed from 13.5 on March 2020 to 92.4 on March 2025 . This represents a CAGR of 37.79% over 6 years.
  • The Market Cap of Albert David Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Laurus Labs Ltd changed from ₹ 3449 crore on March 2020 to ₹ 33099 crore on March 2025 . This represents a CAGR of 45.78% over 6 years.
  • The revenue of Albert David Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Laurus Labs Ltd for the Jun '25 is ₹ 1580 crore as compare to the Mar '25 revenue of ₹ 1778 crore. This represent the decline of -11.18%.
  • The ebitda of Albert David Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Laurus Labs Ltd for the Jun '25 is ₹ 392.56 crore as compare to the Mar '25 ebitda of ₹ 479.17 crore. This represent the decline of -18.08%.
  • The net profit of Albert David Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Laurus Labs Ltd changed from ₹ 28.4 crore to ₹ 161.08 crore over 9 quarters. This represents a CAGR of 116.27% .
  • The Dividend Payout of Albert David Ltd changed from 20.85 % on March 2020 to 16.6 % on March 2025 . This represents a CAGR of -3.73% over 6 yearsThe Dividend Payout of Laurus Labs Ltd changed from 10.13 % on March 2020 to 17.01 % on March 2025 . This represents a CAGR of 9.02% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Albert David Ltd

  • Albert David Limited (ADL), a Unit of Kothari Group, was incorporated in 1938 at Calcutta.
  • The Company belongs to a renowned industrial house of Kolkata, the 'Kothari Group'.
  • The Company's principal business is manufacturing and trading of Pharmaceutical Formulations, Infusion Solutions, Herbal Dosage Forms and Bulk Drugs by way of domestic sale or export.
  • Apart from these, it manufactures disposable syringes and needles and a wide range of bulk drugs.
  • It is recognised as a large IV fluid manufacturer, both in glass and polyethylene containers. ADL has entered into a technical collaboration with Morishita Pharmaceuticals, Japan, a subsidiary of Ajinomoto -- the world leader in amino acids -- to manufacture amino acid infusions, for which it came out with a rights issue in Aug.'87.

About Laurus Labs Ltd

  • Laurus Labs Limited was originally incorporated as 'Laurus Labs Private Limited' on September 19, 2005 at Hyderabad, Andhra Pradesh, India as a private limited company.
  • The company was subsequently converted into a public limited company and its name was changed to Laurus Labs Limited on February 12, 2007.
  • Subsequently the name of the company was changed to Aptuit Laurus Limited consequent to the strategic partnership entered into by the company with Aptuit Singapore on July 19, 2007.
  • Thereafter the company was converted into a private limited company and its name was changed to Aptuit Laurus Private Limited on July 24, 2007.
  • Subsequently, company was converted into a public limited company and the name of the company was changed to Laurus Labs Limited on August 16, 2016. Laurus Labs is a science-led, fully integrated pharmaceutical and biotechnology manufacturing company with a leadership position in generic active pharmaceutical ingredients (APIs) in selected high-growth therapeutic areas of anti-retrovirals (ARVs), Hepatitis C and Oncology.

Albert David Ltd News Hub

News

Albert David to declare Quarterly Results

Albert David will hold a meeting of the Board of Directors of the Company on 2 August 2025...

Read more

26 Jul 2025 09:49

News

Board of Albert David recommends final dividend

Albert David announced that the Board of Directors of the Company at its meeting held on 1...

Read more

14 May 2025 09:11

News

Albert David schedules AGM

Albert David announced that the 86th Annual General Meeting(AGM) of the company will be he...

Read more

14 May 2025 09:11

News

Albert David Ltd leads losers in 'B' group

Mafatlal Industries Ltd, Sportking India Ltd, Platinum Industries Ltd and IKIO Technologie...

Read more

14 May 2025 14:45

News

Albert David schedules board meeting

Albert David will hold a meeting of the Board of Directors of the Company on 13 May 2025. ...

Read more

08 May 2025 11:20

News

Albert David schedules board meeting

Albert David will hold a meeting of the Board of Directors of the Company on 13 May 2025. ...

Read more

07 May 2025 10:54

Laurus Labs Ltd News Hub

News

Volumes spurt at Laurus Labs Ltd counter

Poonawalla Fincorp Ltd, Kajaria Ceramics Ltd, Aadhar Housing Finance Ltd, SBI Life Insuran...

Read more

28 Jul 2025 11:00

News

Laurus Labs Ltd rises for third consecutive session

Laurus Labs Ltd gained for a third straight session today. The stock is quoting at Rs 893....

Read more

28 Jul 2025 13:05

News

Laurus Labs climbs on robust Q1 earnings

Gross margin improved to 59.4% in Q1 June 2025, up from 55.1% in Q1 June 2024. Profit befo...

Read more

28 Jul 2025 14:46

News

Laurus Labs to announce Quarterly Result

Laurus Labs will hold a meeting of the Board of Directors of the Company on 25 July 2025. ...

Read more

10 Jul 2025 10:29

News

Laurus Labs invests Rs 39.99 cr in Laurus Bio

Laurus Labs has invested Rs 39.99 crore and acquired 15,414 Series A2 Compulsorily Convert...

Read more

26 Jun 2025 13:24

News

Laurus Labs Ltd spurts 1.63%, up for five straight sessions

Laurus Labs Ltd rose for a fifth straight session today. The stock is quoting at Rs 680.9,...

Read more

26 Jun 2025 13:00

SWOT Analysis Of Laurus Labs Ltd

Strength

6

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Albert David Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Laurus Labs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Albert David Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Albert David Ltd and Laurus Labs Ltd

Which company has a larger market capitalization, Albert David Ltd or Laurus Labs Ltd?

Market cap of Albert David Ltd is 498 Cr while Market cap of Laurus Labs Ltd is 45,779 Cr

What are the key factors driving the stock performance of Albert David Ltd and Laurus Labs Ltd?

The stock performance of Albert David Ltd and Laurus Labs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Albert David Ltd and Laurus Labs Ltd?

As of August 2, 2025, the Albert David Ltd stock price is INR ₹873.3. On the other hand, Laurus Labs Ltd stock price is INR ₹848.05.

How do dividend payouts of Albert David Ltd and Laurus Labs Ltd compare?

To compare the dividend payouts of Albert David Ltd and Laurus Labs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions